If you have been watching MongoDB stock lately, you know it has been anything but boring. Whether you are a believer in explosive database growth or someone trying to make sense of seemingly lofty ...

MongoDB, Inc. (NASDAQ:MDB) is one of the stocks on Jim Cramer’s radar recently. A caller asked if Cramer is still a proponent ...

Currently trading with a volume of 759,808, the MDB's price is up by 1.82%, now at $339.64. RSI readings suggest the stock is currently may be approaching overbought. Anticipated earnings release is ...

Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a ...

MongoDB (MDB) shares have taken a breather after a strong run in the past three months, climbing more than 42% over that period. Investors are now weighing its momentum in light of recent shifts in ...

As of late October 2025, the U.S. stock market has seen mixed performances with significant developments such as Nvidia reaching a $5 trillion market cap and Federal Reserve Chair Jerome Powell ...

CoreWeave's financial growth trajectory has been stellar. In the second quarter, the company's revenue surged 207% year over ...

Busie's experience building a charter transportation platform from scratch on Confluent's streaming infrastructure demonstrates what becomes possible when organizations adopt data products principles ...

The Russell Midcap® Growth Index (up 2.78%) underperformed the Russell Midcap® Value Index (up 6.16%), losing some momentum after a notably strong second quarter.

Developers aren’t waiting while leadership dithers over a standardized, official AI platform. Better to treat a platform as a ...

As AI becomes ubiquitous in software, Nvidia platform skills will become crucial for developers. The company is trying to ...

The FDA today unveiled a plan to accelerate development of biosimilars in hopes of significantly reducing drug costs in the United States.